BR112013025500A2 - método para detectar contaminantes pró-inflamatórios de polímeros de glicose - Google Patents
método para detectar contaminantes pró-inflamatórios de polímeros de glicoseInfo
- Publication number
- BR112013025500A2 BR112013025500A2 BR112013025500A BR112013025500A BR112013025500A2 BR 112013025500 A2 BR112013025500 A2 BR 112013025500A2 BR 112013025500 A BR112013025500 A BR 112013025500A BR 112013025500 A BR112013025500 A BR 112013025500A BR 112013025500 A2 BR112013025500 A2 BR 112013025500A2
- Authority
- BR
- Brazil
- Prior art keywords
- proinflammatory
- contaminants
- detecting
- glucose polymers
- glucose
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
- 239000000356 contaminant Substances 0.000 title 1
- 239000008103 glucose Substances 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
- 230000000770 proinflammatory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/5055—Cells of the immune system involving macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/22—Testing for sterility conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1153050 | 2011-04-08 | ||
FR1153050 | 2011-04-08 | ||
FR1154342 | 2011-05-19 | ||
FR1154342 | 2011-05-19 | ||
FR1157073 | 2011-08-02 | ||
FR1157073A FR2978774B1 (fr) | 2011-08-02 | 2011-08-02 | Methodes de detection des contaminants des circuits de production de polymeres de glucose |
FR1160921 | 2011-11-29 | ||
FR1160921 | 2011-11-29 | ||
PCT/FR2012/050755 WO2012143647A1 (fr) | 2011-04-08 | 2012-04-06 | Méthodes de détection de contaminants dans des solutions contenants des polymères de glucose |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112013025500A2 true BR112013025500A2 (pt) | 2017-11-14 |
BR112013025500B1 BR112013025500B1 (pt) | 2021-02-02 |
BR112013025500B8 BR112013025500B8 (pt) | 2021-04-06 |
Family
ID=46062619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013025500A BR112013025500B8 (pt) | 2011-04-08 | 2012-04-06 | método para detectar contaminação por peptídoglicanos (pgn) de polímeros de glicose |
Country Status (12)
Country | Link |
---|---|
US (2) | US9494576B2 (pt) |
EP (2) | EP3495816A1 (pt) |
JP (2) | JP5989088B2 (pt) |
KR (1) | KR101918790B1 (pt) |
CN (1) | CN103492878B (pt) |
AU (1) | AU2012246182B2 (pt) |
BR (1) | BR112013025500B8 (pt) |
CA (2) | CA3077116C (pt) |
MX (1) | MX350641B (pt) |
RU (1) | RU2557995C2 (pt) |
SG (2) | SG10201602761TA (pt) |
WO (1) | WO2012143647A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5989088B2 (ja) * | 2011-04-08 | 2016-09-07 | ロケット フレールRoquette Freres | グルコースポリマーに含まれる汚染物質の検出方法 |
CA2873376C (fr) * | 2012-05-29 | 2022-04-19 | Roquette Freres | Methodes de decontamination des circuits de production de polymeres de glucose et d'hydrolysats de polymeres de glucose |
WO2014154651A1 (fr) * | 2013-03-26 | 2014-10-02 | Roquette Freres | Dosage biologique des peptidoglycanes |
MX2016009774A (es) | 2014-02-07 | 2016-11-14 | Roquette Freres | Ensayo biologico de peptidoglicanos. |
US20170081688A1 (en) * | 2014-03-21 | 2017-03-23 | Roquette Freres | Optimized method for decontaminating production of glucose polymers and glucose polymer hydrolyzates |
KR20160066372A (ko) * | 2014-12-02 | 2016-06-10 | (주)바텍이우홀딩스 | 엑스선 센서용 인터페이스 장치와 이를 포함한 엑스선 센서 모듈 |
FR3037063B1 (fr) | 2015-06-04 | 2017-05-19 | Roquette Freres | Procede optimise de decontamination de l'amidon utilise comme matiere premiere pour l'obtention de polymeres de glucose destines a la dialyse peritoneale |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3689863T2 (de) | 1985-06-22 | 1995-01-05 | Ml Lab Plc | In kontinuierlicher Peritonealdialyse verwendete Polymere. |
FR2716199B1 (fr) | 1994-02-15 | 1996-04-26 | Roquette Freres | Procédé de fabrication d'un hydrolysat d'amidon à faible indice de polymolécularité, nouvel hydrolysat d'amidon ainsi obtenu et son utilisation en dialyse péritonéale. |
WO2004094671A2 (en) | 2003-04-22 | 2004-11-04 | Coley Pharmaceutical Gmbh | Methods and products for identification and assessment of tlr ligands |
DK2360479T3 (da) * | 2005-12-22 | 2014-04-07 | Baxter Int | Forbedret monocytaktiveringsprøve til påvisning af pyrogene ikke-endotoxin-forureninger i medicinske produkter |
DE102006031483B4 (de) * | 2006-07-07 | 2009-12-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Zellulärer Pyrogentest |
US20090317838A1 (en) | 2008-03-17 | 2009-12-24 | Jean-Marc Cavaillion | Detection of bacterial peptidoglycan-like compounds |
US20090239819A1 (en) | 2008-03-20 | 2009-09-24 | Run Wang | Peritoneal dialysis solution test method |
US20090239238A1 (en) * | 2008-03-20 | 2009-09-24 | Baxter International Inc. | Methods for measuring pro-inflammatory substance levels in dialysis solutions and dialysis components |
FR2945043B1 (fr) | 2009-04-30 | 2019-07-26 | Roquette Freres | Procede de purification de polymeres de glucose destines aux solutions de dialyse peritoneale |
JP5989088B2 (ja) * | 2011-04-08 | 2016-09-07 | ロケット フレールRoquette Freres | グルコースポリマーに含まれる汚染物質の検出方法 |
WO2014154651A1 (fr) * | 2013-03-26 | 2014-10-02 | Roquette Freres | Dosage biologique des peptidoglycanes |
-
2012
- 2012-04-06 JP JP2014503201A patent/JP5989088B2/ja active Active
- 2012-04-06 CA CA3077116A patent/CA3077116C/fr active Active
- 2012-04-06 KR KR1020137026218A patent/KR101918790B1/ko active IP Right Grant
- 2012-04-06 WO PCT/FR2012/050755 patent/WO2012143647A1/fr active Application Filing
- 2012-04-06 CN CN201280017376.2A patent/CN103492878B/zh active Active
- 2012-04-06 RU RU2013149820/15A patent/RU2557995C2/ru active
- 2012-04-06 SG SG10201602761TA patent/SG10201602761TA/en unknown
- 2012-04-06 AU AU2012246182A patent/AU2012246182B2/en active Active
- 2012-04-06 CA CA2831003A patent/CA2831003C/fr active Active
- 2012-04-06 US US14/110,569 patent/US9494576B2/en active Active
- 2012-04-06 EP EP18214693.6A patent/EP3495816A1/fr active Pending
- 2012-04-06 BR BR112013025500A patent/BR112013025500B8/pt active IP Right Grant
- 2012-04-06 SG SG2013073093A patent/SG194005A1/en unknown
- 2012-04-06 MX MX2013011547A patent/MX350641B/es active IP Right Grant
- 2012-04-06 EP EP12720540.9A patent/EP2694961B2/fr active Active
-
2016
- 2016-08-09 JP JP2016156300A patent/JP6310973B2/ja active Active
- 2016-10-13 US US15/292,281 patent/US11168348B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP5989088B2 (ja) | 2016-09-07 |
MX350641B (es) | 2017-09-11 |
MX2013011547A (es) | 2014-02-28 |
SG10201602761TA (en) | 2016-05-30 |
JP2014510924A (ja) | 2014-05-01 |
EP2694961B1 (fr) | 2019-01-02 |
SG194005A1 (en) | 2013-11-29 |
US9494576B2 (en) | 2016-11-15 |
RU2557995C2 (ru) | 2015-07-27 |
CN103492878B (zh) | 2015-11-25 |
AU2012246182A1 (en) | 2013-10-31 |
BR112013025500B8 (pt) | 2021-04-06 |
BR112013025500B1 (pt) | 2021-02-02 |
CN103492878A (zh) | 2014-01-01 |
CA3077116C (fr) | 2022-07-19 |
EP2694961A1 (fr) | 2014-02-12 |
JP2017018119A (ja) | 2017-01-26 |
US20170030895A1 (en) | 2017-02-02 |
KR20140012119A (ko) | 2014-01-29 |
CA2831003A1 (fr) | 2012-10-26 |
CA2831003C (fr) | 2021-06-01 |
EP2694961B2 (fr) | 2022-01-05 |
EP3495816A1 (fr) | 2019-06-12 |
AU2012246182B2 (en) | 2016-12-01 |
JP6310973B2 (ja) | 2018-04-11 |
US11168348B2 (en) | 2021-11-09 |
RU2013149820A (ru) | 2015-05-20 |
WO2012143647A1 (fr) | 2012-10-26 |
US20140051097A1 (en) | 2014-02-20 |
CA3077116A1 (fr) | 2012-10-26 |
KR101918790B1 (ko) | 2018-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR22C1038I2 (fr) | Procédé de glycoconjugaison | |
CO6930312A2 (es) | Método de notificación de aplicación | |
BR112014005087A2 (pt) | método para detectar nucleossomas contendo nucleotídeos | |
BR112016012160A2 (pt) | métodos para detecção de infecção de plasmodium | |
BR112014002562A2 (pt) | método para monitoramento de fluidos | |
BR112014002252A2 (pt) | métodos para a detecção de modificação de nucleotídeo | |
HK1216736A1 (zh) | 移除軌道的疑似段的方法 | |
BR112014011900A2 (pt) | um método de purificação de anticorpo | |
CU24158B1 (es) | Método de obtención de 1-kestosa | |
DE102012208877A8 (de) | System zur Erfassung bewegter Objekte | |
BR112013028879A2 (pt) | aparelho de filtragem | |
BR112014007958A2 (pt) | método | |
BR112014001237A2 (pt) | método | |
BR112014001851A2 (pt) | método | |
BR112013027644A2 (pt) | método de medição de conformação | |
BR112013030423A2 (pt) | método para produção de biocoque | |
BR112014009795A2 (pt) | método | |
BR112013025500A2 (pt) | método para detectar contaminantes pró-inflamatórios de polímeros de glicose | |
DK2649029T3 (da) | Fremgangsmåde til depolymerisering | |
BR112014016066A2 (pt) | método para detectar micro-organismos salmonella | |
BR112013022820A2 (pt) | método de tratamento | |
DE112012002431A5 (de) | Selbstzentrierende Käfigmutter | |
FR2998290B1 (fr) | Procede de potabilisation | |
BR112014003473A2 (pt) | aparelhos indicadores de condição fisiológica particularizada | |
ES2388959B1 (es) | Procedimiento y aparato de termolisis de polimeros de desecho. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/04/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2613 DE 02/02/2021 QUANTO AO INVENTOR. |